Orexigen, Advaxis, Globalstar, and Piedmont Office Realty Trust all posted new 52-week lows Tuesday.
Newell Brands, Synergy Pharma, Mallinckrodt, and Advaxis all posted new 52-week lows Friday.
HP Enterprise, Discovery Communications, Intercept Technologies, and Advaxis all posted new 52-week lows on Tuesday.
Aldeyra Therapeutics saw its shares slide on Wednesday after the company said its allergic conjunctivitis drug missed the primary endpoint in this Phase 2b trial.
According to one analyst, Advaxis shares could still easily more than double, even after news broke that biotech giant Amgen will become its partner.
Over the past week, Akorn, Celator Pharmaceuticals and a few other biotech companies made impressive runs.
Advaxis made waves in the markets on Monday following the release of positive data from its most recent study.
Advaxis has announced that the FDA has lifted the clinical hold on all of its Investigational New Drug (IND) applications for its three product candidates
There were five analyst calls we tracked in the past week in which an analyst was willing to call for a stock to rise roughly 100%, and some even higher.
Tuesday's top analyst upgrades, downgrades and initiations include Apple, DuPont, Frontier Communications, Hewlett-Packard, HSBC, 3M and Red Hat.
Friday's top analyst upgrades, downgrades and initiations include Apple, Clovis Oncology, Deere, JC Penney, Wynn Resorts and Yum! Brands.